Home Blog Page 430

KuCoin Futures Market Data Now Available on TradingView, Expanding Access to Professional-Grade Analytics

By
Advertorial Desk
-

Integration enables over 100 million TradingView users to access KuCoin’s real-time futures data and liquidity insights

PROVIDENCIALES, Turks and Caicos Islands, April 30, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, today announced that its Futures market data is now fully integrated with TradingView, one of the world’s most widely used charting and trading analysis platforms. This integration enables TradingView’s global user base of over 100 million traders and investors to access KuCoin’s perpetual futures data directly within its advanced charting environment.

By bringing KuCoin Futures data onto TradingView, users can now analyze real-time price movements, monitor liquidity conditions, and build data-driven strategies using one of the industry’s most powerful technical analysis toolsets. The integration reflects KuCoin’s continued commitment to enhancing transparency, accessibility, and institutional-grade infrastructure across the digital asset ecosystem.

Through this integration, users can:

  • Access KuCoin Futures market data in real time directly on TradingView charts
  • Utilize advanced charting tools to analyze market structure, volatility, and trends
  • Set customizable alerts based on KuCoin Futures price movements
  • Develop indicators, strategies, and quantitative models using Pine Script®
  • Incorporate KuCoin data into institutional and systematic trading workflows

The integration is designed to support a wide range of market participants, including professional traders, market makers, quantitative teams, institutional investors, and retail users seeking deeper futures market insights.

Expanding KuCoin Futures data availability to TradingView enhances the exchange’s global reach and ensures users can engage with its markets through best-in-class analytical tools—even outside the KuCoin platform. It also aligns with KuCoin’s broader strategy of building a transparent, scalable, and institution-ready trading infrastructure.

About KuCoin

Founded in 2017, KuCoin is a leading global crypto platform built on trust and security, serving over 40 million users across 200+ countries and regions. Known for its reliability and user-first approach, the platform combines advanced technology, deep liquidity, and strong security safeguards to deliver a seamless trading experience. KuCoin provides access to 1,500+ digital assets through a broad product suite and remains committed to building transparent, compliant, and user-centric digital asset infrastructure for the future of finance, backed by SOC 2 Type II, ISO/IEC 27001:2022, and ISO/IEC 27701:2019 Certifications. In recent years, we have built a strong global compliance foundation, marked by key milestones including AUSTRAC registration in Australia, a MiCA license in Europe, and regulatory progress in other markets.

Learn more at www.kucoin.com.

Disclosure

This integration is intended to provide market data access and analytical functionality only. It does not constitute investment advice, financial advice, trading recommendations, or any solicitation to buy, sell, or hold any securities, derivatives, or other financial instruments. While KuCoin strives to ensure the data is accurately displayed, we do not guarantee the timeliness, accuracy, completeness, or reliability of such data. Data may be delayed, contain errors, or be subject to interruptions.

Trading execution via KuCoin on TradingView is not currently supported.

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

By
Advertorial Desk
-

– Bambusa’s lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic dermatitis (AD) and other type 2 inflammatory skin diseases –

– Bambusa plans to announce topline results from the placebo-controlled Phase 1b/2a trial of BBT001 in moderate-to-severe AD in mid-2026 –

– Previously presented data from the Phase 1 healthy volunteer portion of the BBT001 trial support a potential best-in-disease profile with maintenance dosing of up to every 3 months –

BOSTON, April 30, 2026 /PRNewswire/ — Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation bispecific antibodies for immunology and inflammation, today announced the completion of patient enrollment in its randomized, double-blind, placebo-controlled Phase 1b/2a trial of BBT001 in patients with moderate-to-severe atopic dermatitis (AD). The Company plans to announce topline results from the 4-week treatment study in the middle of 2026.

The Phase 1b/2a trial is a randomized, placebo-controlled study in patients with moderate-to-severe AD at clinical sites located in New Zealand and the United States. Patients were randomized 2 to 1 in favor of the BBT001 450-milligram treatment arm compared to placebo with a dosing interval of once every two weeks over a 4-week period. The primary endpoints of the trial are safety and tolerability. Exploratory efficacy and biomarker endpoints include the percent change in Eczema Area and Severity Index (EASI), Peak Pruritus Numerical Rating Scale (PP-NRS) score, and thymus and activation-regulated chemokine (TARC), relative to baseline.

“We are thrilled with the rapid enrollment of our first clinical trial of BBT001 in patients with moderate-to-severe AD, and we are looking forward to announcing topline results over the summer in 2026,” said Shanshan Xu, M.D., Ph.D., Founder & Chief Executive Officer of Bambusa Therapeutics. “Data from this trial have the potential to establish clinical proof-of-concept for BBT001 in patients with AD. This would be a significant milestone for Bambusa, and a true testament to our team’s hard work in advancing the development of BBT001 over the past two years. We believe BBT001’s multi-target mechanism provides the potential for it to be a highly differentiated, best-in-disease treatment option for patients with AD by improving overall clinical outcomes, quality of life, and dosing convenience compared to currently approved medicines.”

Alongside the 4-week AD study, BBT001 is being evaluated in an ongoing 12-week AD trial and a 14-week chronic spontaneous urticaria (CSU) study.

BBT001 is an investigational therapy that is not approved for any use in any country.

About BBT001

Bambusa Therapeutics’ lead clinical program, BBT001, is a first-in-class, multi-targeting, half-life extended bispecific antibody engineered to block both IL-4Rα and IL-31 signaling. By simultaneously addressing core type 2 inflammation and directly targeting pathways that drive itch, BBT001 is designed to provide faster, deeper, and more durable relief for patients with AD and other type 2 inflammatory skin diseases.

Bambusa has previously presented Phase 1 healthy volunteer data supporting a potential best-in-disease profile for BBT001, including a favorable safety profile, positive pharmacokinetic and pharmacodynamic activity, and the potential for maintenance dosing of up to every three months. Bambusa is currently evaluating BBT001 in multiple ongoing placebo-controlled clinical trials, including studies in patients with AD and CSU.

About Bambusa Therapeutics

Bambusa Therapeutics is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation (I&I) diseases. The Company’s bispecific antibody platform combines advanced protein engineering with half-life extension technology and high-concentration subcutaneous delivery to improve durability, convenience, and clinical differentiation. Bambusa’s vision is to deliver transformative medicines for patients across every stage of life and help define the next era of I&I therapies.

  • BBT001 is a first-in-class, half-life-extended bispecific antibody targeting IL-4Rα and IL-31 with best-in-disease potential. It is currently in Phase 1b/2a proof-of-concept development for AD and other type 2 inflammatory skin diseases.
  • BBT002 is a first-in-class, half-life-extended bispecific antibody targeting IL-4Rα and IL-5 with platform-in-a-molecule potential. It is currently in Phase 1b/2a proof-of-concept development for type 2 inflammatory disorders including chronic obstructive pulmonary disease (COPD) and chronic rhinosinusitis with nasal polyps (CRSwNP).
  • BBT003 and BBT004 are preclinical programs focused on gastroenterology and rheumatology, respectively.

For more information, please visit www.bambusatx.com. Follow Bambusa on LinkedIn. 

 

 

Taoping Reports Fiscal Year 2025 Results

By
Advertorial Desk
-

Strategic Transformation Drives Platform Expansion, Positions Company for Accelerated Growth

TIANJIN, China, April 30, 2026 /PRNewswire/ — Taoping Inc. (Nasdaq: TAOP, the “Company”), a provider of innovative Cloud-based technologies on the Smart City IoT platform, and related products and services, today reported financial results for the year ended December 31, 2025. The Company expects to file its annual report on Form 20-F for the year ended on December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on or about April 30, 2026.

Mr. Bin Ma, Co-CEO of Taoping, said, “Our 2025 financial performance reflects both deliberate strategic realignment and disciplined investment in future growth drivers. While revenue declined year-over-year, we diversified revenue streams and strengthened our balance sheet, positioning the Company to execute on its next phase of growth. We remain focused on improving gross margin through higher-value service offerings and expect operating efficiency to improve as platform revenues scale and recurring income becomes a larger component of our business mix.”

“We are encouraged by the early validation of this strategy. As highlighted by our recent smart elevator expansion, including over $3 million in new orders announced to date, we believe we are well positioned to capitalize on growing demand for intelligent, data-driven infrastructure solutions. While we cannot guarantee future results, we are optimistic about the long-term growth potential of this segment.”

“By integrating proprietary, AI-enabled technologies with real-world operational data, we believe we are not only improving efficiency and safety outcomes for our customers, but also building a scalable platform that positions Taoping at the forefront of intelligent infrastructure transformation. We expect that this approach will unlock meaningful operating leverage, expand margins over time, and create sustainable long-term value for our shareholders.”

Select Fiscal Year 2025 Financial Results

For the fiscal year ended December 31, 2025, Taoping Inc. reported total revenue of $30.8 million, a decrease of approximately 16.0% year-over-year compared to $36.7 million in 2024. The decline primarily reflects the Company’s continued strategic shift away from lower-margin legacy software and transactional businesses toward higher-value platform-based and AI-enabled services.

Gross profit was $3.37 million, compared to $7.77 million in the prior year, reflecting ongoing investments in new business initiatives and a transitional revenue mix.

Operating loss was $9.23 million, compared to $1.61 million in 2024, driven primarily by increased administrative cost and continued scaling of next-generation platform infrastructure. Net loss attributable to the Company was $10.06 million, compared to $1.82 million in the prior year.

Strategic and Operational Update

During 2025, Taoping accelerated its transformation into a technology-driven platform company, focusing on AI, IoT, and data-enabled services.

Management emphasized the Company’s continued strategy to build out its intelligent infrastructure platforms, including smart city, digital media, and IoT-based solutions, while advancing its AI-powered predictive systems and data monetization capabilities.

Additionally, the Company is leveraging advanced technologies, including predictive analytics and intelligent automation, to expand into verticals such as smart infrastructure and elevator lifecycle services, which are expected to generate stable, high-margin recurring revenues over time.

Outlook

Looking ahead, Taoping expects:

  • Continued growth in AI-enabled platform services
  • Expansion of recurring revenue streams and customer retention
  • Gradual improvement in gross margins and operating leverage
  • Execution of a multi-year growth strategy focused on technology leadership and ecosystem expansion
  • Accelerated growth through strategic collaborations and acquisitions

Management believes these initiatives, if successfully executed, will support revenue growth and improved profitability over time as the Company seeks to expand its position in intelligent digital infrastructure and platform services.

About Taoping Inc.

Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative Cloud-based technologies on the Smart City IoT platform, and related products and services. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping’s smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit http://en.taop.com.

Safe Harbor Statement

This press release contains “forward-looking statements” that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: our potential inability to achieve or sustain profitability or reasonably predict our future results; risks related to our strategic transformation, including our ability to successfully transition from legacy businesses to platform-based services; risks related to executing our growth strategy in the smart elevator and intelligent infrastructure markets; our ability to obtain additional financing on acceptable terms if needed; intense competition in the AI, IoT, and smart city technology markets; changes in domestic and foreign laws, regulations and taxes; uncertainties related to China’s legal system and economic, political and social events in China; the volatility of the securities markets; and other risks including, but not limited to, those that we discussed or referred to in the Company’s disclosure documents filed with the U.S. Securities and Exchange Commission (the “SEC”) available on the SEC’s website at www.sec.gov, including the Company’s most recent Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.

Genki AI Global Debut: Scaling IP Management with Autonomous Operation Technology

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 30 April 2026 – Genki AI, an all-in-one AI autonomous engine for IP management, officially launched globally on May 1, 2026. It solves critical pain points in the creator economy: most creators excel at IP incubation but lack skills in product design, supply chain and cross-border operations, while existing tools are fragmented and cause serious “value leakage”.

With the core concept “From Ideas To Income – Instantly”, Genki AI provides a one-click full-chain workflow. Creators only need to upload images or input prompts, and the platform automatically generates IP assets and POD product mock-ups, creates localized e-commerce pages, produces multi-channel marketing materials, and connects global logistics and distribution networks. Unlike traditional e-commerce platforms or single AI tools, it integrates the entire commercial value chain.

In private beta testing, creators launched global stores in less than 15 minutes, far shorter than the traditional 3–6 months. Top IP collections achieved over 3.2% conversion rate and more than $3,250 in first-week sales, reducing backend operation time by 90%.

To celebrate its launch, Genki AI launched the Global Creator Recruitment Program for digital artists. Selected partners can enjoy priority exposure, exclusive onboarding support and favorable revenue sharing, while keeping full IP ownership.

https://www.youtube.com/watch?v=DsD33N_Mluw

Genki AI aims to shift the creator economy from traffic competition to long-term IP value building. It lets creators focus on creation while AI handles complex global commerce. The platform will keep upgrading its AI and cross-border services, helping every creative idea realize global commercial value.

Visit the Website here: https://www.genkios.com/

Hashtag: #GenkiAI

The issuer is solely responsible for the content of this announcement.

SANY Microgrid Breaks Ground on Integrated Solar-Storage Project in Dobrești, Romania, Marking a New Chapter in Green Energy in Europe

By
Advertorial Desk
-

DOBREȘTI, ROMANIA – Media OutReach Newswire – 30 April 2026 – On April 27, SANY Microgrid officially broke ground on its integrated solar-storage project in Dobrești, Romania. Xiang Wenbo, Rotating Chairman of SANY Group; Guo Ruiguang, Vice President of SANY Group and Chairman of SANY Microgrid Business Unit; other senior executives of SANY Group; local government representatives; and project partners joined more than 100 guests to witness this milestone.

At the groundbreaking ceremony, Xiang Wenbo expressed sincere gratitude to the local government and partners for their support, and shared his expectations for the smooth implementation and long-term success of the project. Local government officials emphasized that the project is significant for optimizing the energy mix, creating jobs, and promoting sustainable economic development, and pledged full government support. SANY Microgrid also presented its relevant solutions at the ceremony.

As SANY Microgrid’s first large-scale grid-connected solar-storage demonstration project in Europe, the project will serve as a starting point for advancing renewable energy development and the transition to electric construction machinery across Europe. It will bring green momentum to the local economy, provide a model for Chinese enterprises expanding overseas in green energy transition, and contribute to global green energy development.

“SAN WIN GREEN ENERGY S.R.L. is the Romanian subsidiary supporting SANY’s renewable energy and microgrid expansion in Romania and Europe. The company, represented by Xu Zhongtian, focuses on renewable power development, photovoltaic projects, battery storage systems, EPC coordination, and integrated microgrid opportunities.”

Hashtag: #SANY

The issuer is solely responsible for the content of this announcement.

Tencent Cloud Recognized for Transforming the Future of Media at the 2026 NAB Show Product of the Year Awards

By
Advertorial Desk
-

LAS VEGAS, April 30, 2026 /PRNewswire/ — Tencent Cloud, the cloud business of global technology company Tencent, today announced that two of its innovative solutions for the media industry have been recognized as winners at the 2026 NAB Show Product of the Year Awards, which honors the most significant and innovative products showcased at the NAB Show. Its Video Quality Enhancement and Smart Erase solutions were winners in the Streaming category and Intelligent Technology category.


Diffusion Transformer (DiT) for Video Quality Enhancement and Super-Resolution in Live Streaming

This AI-driven DiT enhancement technology delivers high-fidelity visual quality across diverse use cases such as OTT platforms, live e-commerce, gaming, short-form video, AIGC content generation, and professional video production – beyond the typical livestreaming use case. Powered by cutting-edge DiT architecture—advancing beyond conventional CNN and GAN approaches—it delivers authentic, natural texture details and industry-leading real-time performance across video enhancement scenarios, setting a new global benchmark for video enhancement.

Designed for the global-market, its capabilities include real-time 4K super-resolution—critical for high-resolution devices and immersive experiences across diverse use cases—compression artifact removal to eliminate transmission glitches, 120 FPS frame interpolation for smooth playback, targeted ROI (Face/Text) enhancement, and SDR-to-HDR and color enhancement to deliver lifelike visuals resonating with global audiences. With flexible visual tuning driven by self-developed AI vision large models, the platform smoothly adapts to all kinds of business scenarios such as the low-latency demands of real-time live streaming, steadily improving key operational outcomes, including user quality of experience (QoE), platform watch time, and overall advertising performance.


Smart Erase in the Global Distribution of Short Dramas and E-commerce

Complementing the DiT enhancement solution, Smart Erase is an intelligent video processing tool that enables seamless blurring, mosaicking or removal of logos, subtitles, faces and license plates. It automates privacy protection for sensitive visual elements, and is widely adopted by short drama platforms, cross-border e-commerce brands and independent media studios to streamline global content localization and expand content reach worldwide.

Its core capabilities include AI-driven subtitle removal, logo removal, and privacy protection (automatic blur/mosaicking of faces and license plates). Built on Latent Space Transformers, its end-to-end generative architecture ensures seamless restoration, while flexible modes (Automatic, Designated Region, Hybrid) and batch processing support massive video volumes, integrating with OCR, translation, and AI dubbing for efficient multi-language content localization.


With over 20 years of experience in audio and video technologies, Tencent Cloud Media Services provide industry-leading and comprehensive one-stop solutions from content creation, media processing, to streaming and secure, accelerated distribution. The services cover a full range of scenario-specific media AI capabilities, including industry-leading AI visual enhancement (frame interpolation, super resolution, SDR-to-HDR, color enhancement), AI-driven content generation (text-to-image, image-to-image, reference-based multi-image generation, text-to-video, image-to-video), AI-enhanced workflow tools (object removal, translation, voice cloning & dubbing, large model understanding, highlight auto-clipping) , among others.

“Securing two NAB Show awards is a testament to Tencent Cloud’s dedication to building AI-driven video technologies that solve the most pressing challenges facing global media, e-commerce, and gaming partners,” said Gary Hsu, Head of Media  Solutions, North America. “Our DiT enhancement solution is not limited to live streaming—it elevates visual quality across OTT, live e-commerce, gaming, short videos, AIGC, and professional production—while Smart Erase simplifies global content localization, reducing costs and improving efficiency. Both innovations are designed to support our partners stand out in a competitive global market.”


“These awards reinforce that our focus on user-centric innovation is resonating globally,” added Gary. “DiT addresses the trade-off between visual quality and speed, delivering cinema-grade experiences without latency, while Smart Erase automates tedious content cleanup and localization—empowering brands to accelerate time-to-market and broaden their global reach. We’re proud to lead the industry in redefining what’s possible with video technology, and we’re excited to continue empowering our global partners to thrive.”

NAB Show Product of the Year Award winners were selected by a panel of industry experts in 16 categories and announced in a live awards ceremony at NAB Show on April 22.

“NAB is honored to recognize the some of the industry’s most innovative products that are shaping the future of content creation, distribution and monetization,” said Eric Trabb, senior vice president, Strategic Alliances & Partnerships at NAB, “Congratulations to Tencent Cloud on earning the 2026 NAB Show Product of the Year Award for ‘Diffusion Transformer (DiT) for Video Quality Enhancement and Super-Resolution in Live Streaming’ and ‘Smart Erase in the Global Distribution of Short Dramas and E-commerce’— a cutting-edge solution enhancing a critical stage of the content lifecycle and helping storytellers succeed in today’s dynamic media landscape.”

Visit the Product of the Year Awards – NAB Show for more information about the 2026 NAB Show Product of the Year Awards.

About Tencent Cloud

Tencent Cloud, one of the world’s leading cloud companies, is committed to creating innovative solutions to resolve real-world issues and enabling digital transformation for smart industries. Through our extensive global infrastructure, Tencent Cloud provides businesses across the globe with stable and secure industry-leading cloud products and services, leveraging technological advancements such as cloud computing, Big Data analytics, AI, IoT, and network security. It is our constant mission to meet the needs of industries across the board, including the fields of gaming, media and entertainment, finance, healthcare, property, retail, travel, and transportation.

GameAbove Golf Among Lead Investors in McLaren Golf, Expands Strategic Position in the Global Premium Golf Equipment Market

By
Advertorial Desk
-

Investment reinforces GameAbove’s long-term commitment to performance-driven innovation in global golf

FORT MYERS, Fla., April 30, 2026 /PRNewswire/ — GameAbove Golf today announced it is among lead investors in McLaren Golf. This investment expands GameAbove’s presence in the global golf industry and aligns it with one of the most recognized performance brands in sport.

On April 29, 2026, in Miami, McLaren Golf introduced its precision-designed Series 1 and Series 3 irons, coinciding with the Miami Grand Prix and PGA Tour’s Miami events. This launch reflects a broader shift toward premium, performance-focused equipment and global brands.

For GameAbove Golf, this investment is a strategic decision to support ventures that combine brand strength, technical expertise, and global scalability in premium sports segments.

“GameAbove invests in organizations that are built to lead,” said Keith J. Stone, Founder and Chairman of GameAbove. “McLaren has spent decades proving that precision engineering, data-driven development, and a relentless pursuit of performance can redefine an industry. Applying that philosophy to golf equipment is both logical and transformative. We see this as a pivotal moment for the game and a strategic opportunity to help shape its future.”

Golf continues to evolve into a performance-driven global market, with growing demand for differentiated products driven by materials science, data-driven design, and measurable results. By entering the equipment category, McLaren brings decades of competitive development expertise to a sport where consistency, repeatability, and confidence are essential. GameAbove’s investment is based on this alignment.

“Elite performance is not accidental; it is engineered,” said Adam Squire, Director of Sports Operations at GameAbove. “McLaren’s DNA is rooted in pushing technical boundaries and delivering a competitive edge you can measure. Bringing that capability into golf equipment creates a compelling new benchmark. From an investment standpoint, this is about backing a brand with structural advantages, engineering expertise, global reach, and an uncompromising commitment to performance.”

McLaren Golf uses Metal Injection Molding (MIM) for its irons, an advanced process rarely used at scale in golf because of its complexity and cost. MIM gives McLaren Golf precision control over material composition, internal geometry, and mass distribution, unlocking freedom not possible with traditional forging or casting. Every gram of weight, structural element, and performance characteristic can be intentionally designed.

This granular process reflects McLaren’s philosophy for supercars and racing: no detail is too small, and no gain is too marginal.

This announcement highlights GameAbove Golf’s ambition to become a leading strategic investor in the golf industry. With strong global participation and rising demand for premium equipment, GameAbove aims to partner with ventures that elevate standards and expand internationally.

About McLaren Golf
McLaren Golf is a high-performance golf equipment company built on the engineering DNA of McLaren Racing and McLaren Automotive.

With operations at the McLaren Technology Centre (MTC) in Woking, England and in Carlsbad, California — a global hub for golf equipment design, engineering and development — McLaren Golf brings together leading minds from both industries to advance the boundaries of design, materials and manufacturing. Visit mclarengolf.com to learn more.

About GameAbove
GameAbove is a privately held global investment company backed by CapStone Holdings Inc. Brands include GameAbove Sports, GameAbove Golf, GameAbove Entertainment and GameAbove Giving. GameAbove is rooted in philanthropy and dedicated to inspiring greatness through sports, entertainment, technology and youth academies. To learn more, visit GameAbove.com.

Follow GameAbove on Facebook, Instagram and LinkedIn @GameAbove, X @Game_Above and YouTube @GameAbove.

 

For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health

By
Advertorial Desk
-

A first-of-its-kind multi-country adult respiratory health awareness campaign is now live across Singapore, Malaysia, Indonesia, and the Philippines

SINGAPORE, April 30, 2026 /PRNewswire/ — In conjunction with World Immunisation Week, Pfizer Singapore, together with healthcare professionals, has launched “For the Reasons that Matter”, a public awareness campaign focused on adult respiratory health. Rolling out simultaneously across Singapore, Malaysia, Indonesia and the Philippines, the campaign brings together medical experts and healthcare professionals to raise awareness of how serious respiratory illnesses, including COVID-19, influenza, RSV and pneumococcal pneumonia, can affect quality of life, independence and the ability to remain present for the people and responsibilities that matter most.

“Across all four of our markets, we are seeing a clear gap between what adults want for their health and the steps they take to protect it. Many adults care deeply about staying well, yet conversations about respiratory health are often delayed until something feels urgent. ‘For the Reasons that Matter’ was created to make this conversation more relevant, more human and more actionable. It is about helping adults stay well, with healthcare professionals playing a vital role in guiding those conversations,” said Ms Deborah Seifert, Cluster Lead, Pfizer Malaysia, Singapore, Indonesia and the Philippines.

Singapore sees even greater urgency for action due to their high proportion of elderly. The country is projected to attain super-aged status in 2026, with one in four citizens aged 65 and above by 2030. In addition, pneumonia accounts for a high burden of disease, causing approximately 20% of deaths in Singapore from 2022-2024, and is one of the country’s leading causes of mortality, according to the Ministry of Health Singapore.

World Immunization Week, observed annually in the last week of April, is a reminder that the science of protection has no age limit. Serious respiratory illnesses, including influenza, COVID-19, RSV and pneumococcal pneumonia, are not only childhood concerns. For adults in Singapore, particularly those managing existing health conditions or entering the decades of greatest vulnerability, they can interrupt working lives, strain families and trigger complications with lasting consequences for health and independence.

“When it comes to respiratory illness such as pneumococcal pneumonia, influenza, COVID-19 and RSV, many are genuinely surprised to learn how their age or underlying conditions may affect their risk profile. A regular visit to a trusted healthcare professional is the best opportunity to have that conversation, and this campaign helps create the conditions for it to happen,” said Dr. Lim Wee Peng, Family Physician and Medical Director at Parkway Shenton.

At the heart of the campaign is a simple but powerful truth: adults protect their health not for health’s sake alone, but for the people and the life they cannot afford to lose.

Adults, particularly those who may be at increased risk, should speak to a healthcare professional about their respiratory health and how to better protect themselves against serious respiratory illnesses such as pneumococcal pneumonia, influenza, COVID-19 and RSV.

1...429430431...6,480Page 430 of 6,480